| Literature DB >> 24841334 |
Kyung-Hwan Oh1, Dong Wook Kim2, Su-Mi Jung1, Seung-Hak Cho1.
Abstract
Enterotoxigenic Escherichia coli (ETEC) is one of the major causes of infectious diarrhea in developing countries. In order to characterize the molecular features of human ETEC isolates from Korea, we investigated the profiles of enterotoxin and colonization factor (CF) genes by polymerase chain reaction (PCR) and performed multilocus sequence typing (MLST) with a total of 291 ETEC strains. The specimens comprised 258 domestic strains isolated from patients who had diarrhea and were from widely separated geographic regions in Korea and 33 inflow strains isolated from travelers visiting other Asian countries. Heat-stable toxin (STh)-possessing ETEC strains were more frequent than heat-labile toxin (LT)-possessing ETEC strains in the domestic isolates, while the detection rates of both enterotoxin genes were similar in the inflow isolates. The profile of CF genes of domestic isolates was similar to that of inflow isolates and the major CF types of the strains were CS3-CS21-CS1/PCF071 and CS2-CS3-CS21. Most of these 2 CF types were detected in ETEC strains that possess both lt and sth genes. The major MLSTST types of domestic isolates were ST171 and ST955. Moreover, the 2 major CF types were usually found concomitantly with the 2 major MLST STs, ST171 and ST955. In conclusion, our genotyping results may provide useful information for guiding the development of geographically specific vaccines against human ETEC isolates.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24841334 PMCID: PMC4026316 DOI: 10.1371/journal.pone.0096896
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primer pairs of multiplex PCR for the detection of CFs.
| Multiplex PCR group | SFs | Primer name | Sequence (5′ to 3′) | Product size (bp) | References |
| Group 1 | CFAI | CFAI-F | TGAGTGCTTCWGCAGTAGAGA | 204 | 20 |
| CFAI-R |
| ||||
| CS6 | CS6-F |
| 416 | 20 | |
| CS6-R |
| ||||
| CS4 | CS4-F | TGAGTGCTTCWGCAGTAGAGA | 300 | 20 | |
| CS4-R |
| ||||
| CS14 | CS14-F | TGAGTGCTTCWGCAGTAGAGA | 357 | 20 | |
| CS14-R |
| ||||
| Group 2 | CS3 | CS3-F |
| 136 | 20 |
| CS3-R |
| ||||
| CS5 | CS5-F |
| 235 | 20 | |
| CS5-R |
| ||||
| CS7 | CS7-F |
| 418 | 20 | |
| CS7-R |
| ||||
| CS15 | CS15-F |
| 364 | 20 | |
| CS15-R |
| ||||
| CS18 | CS18-F |
| 502 | 20 | |
| CS18-R |
| ||||
| CS12 | CS12-F |
| 562 | 20 | |
| CS12-R |
| ||||
| Group 3 | CS2 | CS2-F |
| 140 | 20 |
| CS2-R |
| ||||
| CS17/19 | CS17/19-F | ACTCTRTCGCATTAACCTATTCT | 169 | 20 | |
| CS17/19-R |
| ||||
| CS8 | CS8-F | TATGAGCCTKCTGGAAGTYATCAT | 526 | 20 | |
| CS8-R |
| ||||
| CS21 | CS21-F | TATGAGCCTKCTGGAAGTYATCAT | 292 | 20 | |
| CS21-R |
| ||||
| CS1/PCF071R | CS1/PCF071R-F | ACTCTRTCGCATTAACCTATTCT | 334 | 20 | |
| CS1/PCF071R-R |
| ||||
| CS22 | CS22-F |
| 442 | 20 | |
| CS22-R |
| ||||
| Group 4 | CS13 | CS13-F |
| 212 | 20 |
| CS13-R |
| ||||
| CS20 | CS20-F |
| 413 | 20 | |
| CS20-R |
|
Primer epairs used for MLST.
| Locus | Primer name | Sequence (5′ to 3′) | Product size (bp) |
| aspC | aspC-F4 |
| 594 |
| aspC-R7 |
| ||
| clpX | clpX-F6 |
| 672 |
| clpX-R1 |
| ||
| fadD | fadD-F6 |
| 580 |
| fadD-R3 |
| ||
| icdA | icd-F2 |
| 669 |
| icd-R2 |
| ||
| lysP | lysP-F1 |
| 628 |
| lysP-R8 |
| ||
| mdh | mdh-F3 |
| 650 |
| mdh-R4 |
| ||
| uidA | uidA-277F |
| 658 |
| uidA-277R |
|
Prevalence of enterotoxins of ETEC isolates.
| Enterotoxin types | No. of Domestic isolates (n = 258) | No. of Inflow isolates (n = 33) |
|
| LT | 42 (16.3%) | 12 (36.4%) | 0.008 |
| STh | 94 (36.4%) | 11 (33.3%) | 0.443 |
| LT/STh | 122 (47.3%) | 10 (30.3) | 0.047 |
Data represent results of the Fisher exact test comparing toxin types in domestic isolates and inflow isolates.
Figure 1Profile of colonization factor (CF) genes in domestic and inflow isolates.
Prevalence of CFs and enterotoxins of ETEC isolates.
| CF types | Domestic isolates | Inflow isolates | ||||||
| No. of CFs-type | No. of LT | No. of STh | No. of LT/STh | No. of CFs-type | No. of LT | No. of STh | No. of LT/STh | |
| CS3-CS21-CS1/PCF071 | 38 | 0 | 2 | 36 | 4 | 0 | 0 | 4 |
| CS2-CS3-CS21 | 31 | 0 | 0 | 31 | 1 | 0 | 0 | 1 |
| CS6 | 22 | 11 | 7 | 4 | 6 | 6 | 0 | 0 |
| CS14 | 15 | 2 | 9 | 4 | 0 | 0 | 0 | 0 |
| CS2-CS3 | 5 | 1 | 0 | 4 | 5 | 0 | 1 | 4 |
| CS3 | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 |
| CS3-CS21 | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 |
| CS21-CS1/PCF071 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| CS21 | 1 | 0 | 0 | 1 | 3 | 0 | 3 | 0 |
| CS3-CS1/PCF071 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| CS6-CS8 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 |
| CS3-CS4-CS1/PCF071 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| CS2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| CS12 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CS13 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CS4-CS6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CS4-CS6-CS21 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| NT | 122 | 25 | 75 | 22 | 11 | 5 | 6 | 0 |
| Total | 258 | 42 | 94 | 122 | 33 | 12 | 11 | 10 |
NT; non typable.
Figure 2MLST sequence types in domestic and inflow isolates.
Prevalence of MLST sequence types and CF types of domestic and inflow isolates.
| Isolate groups | Major MLST sequence types (n) | No. of major – and oter CF types | ||||||
| CS3-CS21-CS1/PCF071 | CS2-CS3-CS21 | CS6 | CS14 | CS2-CS3 | Etc. | NT | ||
| Domestic isolates | ST171 (62) | 15 | 13 | 3 | 0 | 2 | 8 | 21 |
| ST955 (53) | 19 | 16 | 1 | 0 | 2 | 7 | 8 | |
| ST964 (18) | 0 | 1 | 0 | 0 | 0 | 0 | 17 | |
| ST656 (18) | 0 | 0 | 1 | 0 | 0 | 0 | 17 | |
| ST949 (8) | 2 | 0 | 2 | 0 | 0 | 0 | 4 | |
| Inflow isolates | ST949 (5) | 0 | 0 | 1 | 0 | 0 | 1 | 3 |
| ST171 (4) | 0 | 1 | 0 | 0 | 0 | 0 | 3 | |
| ST273 (4) | 4 | 0 | 0 | 0 | 0 | 0 | 0 | |
| ST951 (4) | 0 | 0 | 0 | 0 | 4 | 0 | 0 | |
etc.: Includes types present at lower incidence than the major types, NT; non typable.
Figure 3Phylogenetic networks of the isolates according to MLST STs.
The sizes of the circles are proportional to the number of MLST STs. The major MLST STs such as ST171 and ST955 were 23% (66/291) and 19% (55/291).
Comparison of antibiotic resistance of domestic and inflow isolates.
| Antibicrobial agents | Antibiotic resistances (%) of isolates | |
| Domestic isolates | Inflow isolates | |
|
| ||
| Ampicillin (AM) | 30 | 49 |
|
| ||
| Ampicillin-sulbactam (SAM) | 11 | 28 |
| Amoxicillin/Clavulanic Acid (AMC) | 3 | 3 |
|
| ||
| Cephalothin (CF) | 12 | 27 |
| Cefazolin (CZ) | 10 | 21 |
| Ceftriaxone (CRO) | 3 | 12 |
| Cefotaxime (CTX) | 3 | 12 |
| Cefoxitin (FOX) | 2 | 0 |
|
| ||
| Imipenem (IPM) | 0 | 0 |
|
| ||
| Nalidixic Acid (NA) | 38 | 36 |
| Ciprofloxacin (CIP) | 2 | 0 |
|
| ||
| Amikacin (AN) | 0 | 0 |
| Gentamicin (GM) | 5 | 0 |
|
| ||
| Tetracycline (TE) | 29 | 18 |
|
| ||
| Chloramphenicol (C) | 3 | 0 |
|
| ||
| Trimethoprim-sulfamethoxazole (SXT) | 26 | 27 |